Drug Cos. Deride FTC's Lidoderm, Opana Antitrust Suit

Endo, Allergan and Impax on Friday said the U.S. Federal Trade Commission could not pursue claims in a Pennsylvania federal court that the companies unlawfully delayed generic drug competition for Opana...

Already a subscriber? Click here to view full article